{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:13:24Z","timestamp":1790104404622,"version":"4.0.1"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["82304972"],"award-info":[{"award-number":["82304972"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009103","name":"Shaanxi Provincial Department of Education","doi-asserted-by":"publisher","award":["23JK0413"],"award-info":[{"award-number":["23JK0413"]}],"id":[{"id":"10.13039\/501100009103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders, with diarrhea predominant IBS (IBS-D) as the most common subtype. Increasing evidence reported that the gut microbiota-mediated serotonin pathway plays a crucial role in the pathogenesis of IBS-D. In this study, potential herbal medicine, plant extracts and its monomers that can be employed as the candidate molecules for IBS-D through gut microbiota-mediated serotonin pathway were reviewed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>The bacteria indigenous to gut microbiota regulates serotonin pathway, mainly increasing tryptophan hydroxylase (TPH) and decreasing serotonin reuptake transporter (SERT), by activating cyclooxygenase\/prostaglandin E2 (COX\/PGE2) signaling. It further accelerated gastrointestinal motility and visceral hyperalgesia. Herbal medicine prescription including Tongxie yaofang and Shugan decoction, as well as some monomers of flavonoid and polyphenol compounds can be regarded as the potential agents for IBS-D. The predominate mechanisms were related to regulating serotonin pathway by driving on the specific bacterial abundance (such as Firmicutes and Bacteroidetes). However, there are few reports on which specific bacteria species play a regulatory role in serotonin pathway, and most of these effective agents were only evidenced by preclinical studies. We hope this review will provide some useful directions for the treatment strategy of IBS-D.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpp\/rgad120","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T23:08:47Z","timestamp":1704928127000},"page":"75-85","source":"Crossref","is-referenced-by-count":10,"title":["Natural products derived from herbs as promising source for diarrhea predominant-irritable bowel syndrome <i>via<\/i> gut microbiota\u2013serotonin pathway"],"prefix":"10.1093","volume":"76","author":[{"given":"Mengmeng","family":"Zhang","sequence":"first","affiliation":[{"name":"College of Pharmacy, Shaanxi University of Chinese Medicine , Xianyang 712046 ,","place":["P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Dang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shaanxi University of Chinese Medicine , Xianyang 712046 ,","place":["P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5464-8855","authenticated-orcid":false,"given":"Yao","family":"Li","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shaanxi University of Chinese Medicine , Xianyang 712046 ,","place":["P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PeiFeng","family":"Wei","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shaanxi University of Chinese Medicine , Xianyang 712046 ,","place":["P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0475-1798","authenticated-orcid":false,"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shaanxi University of Chinese Medicine , Xianyang 712046 ,","place":["P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwei","family":"Dong","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shaanxi University of Chinese Medicine , Xianyang 712046 ,","place":["P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"2024103012041994100_CIT0001","first-page":"865","article-title":"Diagnosis and treatment of irritable bowel syndrome: a review","volume-title":"JAMA","author":"Camilleri","year":"2021"},{"key":"2024103012041994100_CIT0002","first-page":"1675","article-title":"Irritable bowel syndrome","volume-title":"Lancet","author":"Ford","year":"2020"},{"key":"2024103012041994100_CIT0003","first-page":"908","article-title":"Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis","volume-title":"Lancet Gastroenterol Hepatol","author":"Oka","year":"2020"},{"key":"2024103012041994100_CIT0004","first-page":"712","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume-title":"Clin Gastroenterol Hepatol","author":"Lovell","year":"2012"},{"key":"2024103012041994100_CIT0005","first-page":"473","article-title":"Global burden of irritable bowel syndrome: trends, predictions and risk factors","volume-title":"Nat Rev Gastroenterol Hepatol","author":"Black","year":"2020"},{"key":"2024103012041994100_CIT0006","first-page":"1460","article-title":"Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome","volume-title":"Cell","author":"Mars","year":"2020"},{"key":"2024103012041994100_CIT0007","first-page":"859","article-title":"Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study","volume-title":"Gut","author":"El-Salhy","year":"2020"},{"key":"2024103012041994100_CIT0008","first-page":"983","article-title":"Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity","volume-title":"ISME J","author":"Han","year":"2022"},{"key":"2024103012041994100_CIT0009","first-page":"97","article-title":"Gut microbiota in patients with irritable bowel syndrome","volume-title":"Gastroenterology","author":"Pittayanon","year":"2019"},{"key":"2024103012041994100_CIT0010","first-page":"1962","article-title":"Mucosal serotonin reuptake transporter expression in irritable bowel syndrome is modulated by gut microbiota via mast cell-prostaglandin E2","volume-title":"Gastroenterology","author":"Gao","year":"2022"},{"key":"2024103012041994100_CIT0011","first-page":"438","article-title":"A clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome","volume-title":"J Clin Invest","author":"Zhao","year":"2020"},{"key":"2024103012041994100_CIT0012","first-page":"153","article-title":"Interactions between crude drug extracts used in Japanese traditional Kampo medicines and organic anion-transporting polypeptide 2B1","volume-title":"J Ethnopharmacol","author":"Iijima","year":"2018"},{"key":"2024103012041994100_CIT0013","first-page":"955421","article-title":"Wenshen-Jianpi prescription, a Chinese herbal medicine, improves visceral hypersensitivity in a rat model of IBS-D by regulating the MEK\/ERK signal pathway","volume-title":"Front Pharmacol","author":"Jiang","year":"2022"},{"key":"2024103012041994100_CIT0014","first-page":"154350","article-title":"Tong-Xie-Yao-Fang alleviates diarrhea-predominant irritable bowel syndrome in rats via the GCN2\/PERK-eIF2\u03b1-ATF4 signaling pathway","volume-title":"Phytomedicine","author":"Zhang","year":"2022"},{"key":"2024103012041994100_CIT0015","first-page":"904657","article-title":"Systematic review and meta-analysis of Chinese herbal formula Tongxie yaofang for diarrhea-predominant irritable bowel syndrome: evidence for clinical practice and future trials","volume-title":"Front Pharmacol","author":"Liang","year":"2022"},{"key":"2024103012041994100_CIT0016","first-page":"116672","article-title":"Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: a network meta-analysis of double-blinded, placebo-controlled trials","volume-title":"J Ethnopharmacol","author":"Liu","year":"2023"},{"key":"2024103012041994100_CIT0017","first-page":"1821","article-title":"Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation","volume-title":"Acta Pharmacol Sin","author":"Zhang","year":"2021"},{"key":"2024103012041994100_CIT0018","first-page":"113925","article-title":"Atractylodes oil alleviates diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and intestinal barrier via SCF\/c-kit and MLCK\/MLC2 pathways","volume-title":"J Ethnopharmacol","author":"Xie","year":"2021"},{"key":"2024103012041994100_CIT0019","first-page":"1189971","article-title":"Ameliorative effect of aconite aqueous extract on diarrhea is associated with modulation of the gut microbiota and bile acid metabolism","volume-title":"Front Pharmacol","author":"Zhang","year":"2023"},{"key":"2024103012041994100_CIT0020","first-page":"33","article-title":"Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis","volume-title":"Cell Host Microbe","author":"Zhai","year":"2023"},{"key":"2024103012041994100_CIT0021","first-page":"106291","article-title":"Saccharomyces boulardii, a yeast probiotic, inhibits gut motility through upregulating intestinal serotonin transporter and modulating gut microbiota","volume-title":"Pharmacol Res","author":"Gu","year":"2022"},{"key":"2024103012041994100_CIT0022","first-page":"G80","article-title":"Human-derived gut microbiota modulates colonic secretion in mice by regulating 5-HT3 receptor expression via acetate production","volume-title":"Am J Physiol Gastrointest Liver Physiol","author":"Bhattarai","year":"2017"},{"key":"2024103012041994100_CIT0023","first-page":"677","article-title":"The intestinal epithelium: central coordinator of mucosal immunity","volume-title":"Trends Immunol","author":"Allaire","year":"2018"},{"key":"2024103012041994100_CIT0024","first-page":"19","article-title":"Tales from the crypt: new insights into intestinal stem cells","volume-title":"Nat Rev Gastroenterol Hepatol","author":"Gehart","year":"2019"},{"key":"2024103012041994100_CIT0025","first-page":"837166","article-title":"Potential roles of enterochromaffin cells in early life stress-induced irritable bowel syndrome","volume-title":"Front Cell Neurosci","author":"Tao","year":"2022"},{"key":"2024103012041994100_CIT0026","first-page":"1745","article-title":"Early life stress disrupts intestinal homeostasis via NGF-TrkA signaling","volume-title":"Nat Commun","author":"Wong","year":"2019"},{"key":"2024103012041994100_CIT0027","first-page":"473","article-title":"Serotonin signalling in the gut","volume-title":"Nat Rev Gastroenterol Hepatol","author":"Mawe","year":"2013"},{"key":"2024103012041994100_CIT0028","first-page":"10235","article-title":"Enteric microbiota-mediated serotonergic signaling in pathogenesis of irritable bowel syndrome","volume-title":"Int J Mol Sci","author":"Mishima","year":"2021"},{"key":"2024103012041994100_CIT0029","first-page":"3298","article-title":"Morinda officinalis oligosaccharides increase serotonin in the brain and ameliorate depression via promoting 5-hydroxytryptophan production in the gut microbiota","volume-title":"Acta Pharm Sin B","author":"Zhang","year":"2022"},{"key":"2024103012041994100_CIT0030","first-page":"1357","article-title":"The gut microbiota regulates bone mass in mice","volume-title":"J Bone Miner Res","author":"Sj\u00f6gren","year":"2012"},{"key":"2024103012041994100_CIT0031","first-page":"3698","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites","volume-title":"Proc Natl Acad Sci USA","author":"Wikoff","year":"2009"},{"key":"2024103012041994100_CIT0032","first-page":"264","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume-title":"Cell","author":"Yano","year":"2015"},{"key":"2024103012041994100_CIT0033","first-page":"316","article-title":"Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome","volume-title":"BMC Microbiol","author":"Yang","year":"2021"},{"key":"2024103012041994100_CIT0034","first-page":"495","article-title":"Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine","volume-title":"Cell Host Microbe","author":"Williams","year":"2014"},{"key":"2024103012041994100_CIT0035","first-page":"223","article-title":"Physiological responses of guinea-pig myenteric neurons secondary to the release of endogenous serotonin by tryptamine","volume-title":"Neuroscience","author":"Takaki","year":"1985"},{"key":"2024103012041994100_CIT0036","first-page":"10322","article-title":"Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine","volume-title":"Sci Rep","author":"Cao","year":"2017"},{"key":"2024103012041994100_CIT0037","first-page":"2195","article-title":"Prostaglandin E2, produced by mast cells in colon tissues from patients with irritable bowel syndrome, contributes to visceral hypersensitivity in mice","volume-title":"Gastroenterology","author":"Grabauskas","year":"2020"},{"key":"2024103012041994100_CIT0038","first-page":"532","article-title":"Effect of Bacillus subtilis, Enterococcus faecium, and Enterococcus faecalis supernatants on serotonin transporter expression in cells and tissues","volume-title":"World J Gastroenterol","author":"Chen","year":"2022"},{"key":"2024103012041994100_CIT0039","first-page":"59","article-title":"Lactobacillus acidophilus and Bifidobacterium longum supernatants upregulate the serotonin transporter expression in intestinal epithelial cells","volume-title":"Saudi J Gastroenterol","author":"Cao","year":"2018"},{"key":"2024103012041994100_CIT0040","first-page":"338","article-title":"Effect of Lactobacillus rhamnosus GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel syndrome","volume-title":"World J Gastroenterol","author":"Cao","year":"2018"},{"key":"2024103012041994100_CIT0041","first-page":"2064","article-title":"Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut","volume-title":"Nat Microbiol","author":"Fung","year":"2019"},{"key":"2024103012041994100_CIT0042","first-page":"953","article-title":"Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea","volume-title":"Clin Gastroenterol Hepatol","author":"Fukudo","year":"2014"},{"key":"2024103012041994100_CIT0043","first-page":"358","article-title":"Ramosetron reduces symptoms of irritable bowel syndrome with diarrhea and improves quality of life in women","volume-title":"Gastroenterology","author":"Fukudo","year":"2016"},{"key":"2024103012041994100_CIT0044","first-page":"1035","article-title":"Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial","volume-title":"Lancet","author":"Camilleri","year":"2000"},{"key":"2024103012041994100_CIT0045","first-page":"1617","article-title":"A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea","volume-title":"Gut","author":"Garsed","year":"2014"},{"key":"2024103012041994100_CIT0046","first-page":"4852","article-title":"Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction","volume-title":"World J Gastroenterol","author":"Shi","year":"2015"},{"key":"2024103012041994100_CIT0047","first-page":"995567","article-title":"No synergistic effect of fecal microbiota transplantation and Shugan decoction in water avoidance stress-induced IBS-D rat model","volume-title":"Front Microbiol","author":"Meng","year":"2022"},{"key":"2024103012041994100_CIT0048","first-page":"908","article-title":"Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial","volume-title":"Trials","author":"Wang","year":"2020"},{"key":"2024103012041994100_CIT0049","first-page":"160","article-title":"Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome","volume-title":"Aliment Pharmacol Ther","author":"Chen","year":"2018"},{"key":"2024103012041994100_CIT0050","first-page":"1110","article-title":"Tong-Xie-Yao-Fang regulates 5-HT level in diarrhea predominant irritable bowel syndrome through gut microbiota modulation","volume-title":"Front Pharmacol","author":"Li","year":"2018"},{"key":"2024103012041994100_CIT0051","first-page":"4536","article-title":"Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P","volume-title":"World J Gastroenterol","author":"Yin","year":"2015"},{"key":"2024103012041994100_CIT0052","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/aps.2014.170","article-title":"Herbal prescription Chang\u2019an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome","volume":"36","author":"Wang","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"2024103012041994100_CIT0053","first-page":"778032","article-title":"Effects of Chang-Kang-Fang formula on the microbiota-gut-brain axis in rats with irritable bowel syndrome","volume-title":"Front Pharmacol","author":"Ling","year":"2022"},{"key":"2024103012041994100_CIT0054","first-page":"123","article-title":"Chemical profiles and pharmacological activities of Chang-Kang-Fang, a multi-herb Chinese medicinal formula, for treating irritable bowel syndrome","volume-title":"J Ethnopharmacol","author":"Mao","year":"2017"},{"key":"2024103012041994100_CIT0055","first-page":"1160783","article-title":"Evaluation of the effectiveness and mechanism of action of the Chang-Kang-Fang formula combined with bifid triple viable capsules on diarrhea-predominant irritable bowel syndrome","volume-title":"Front Microbiol","author":"Sun","year":"2023"},{"key":"2024103012041994100_CIT0056","first-page":"249","article-title":"Relieving visceral hyperalgesia effect of Kangtai capsule and its potential mechanisms via modulating the 5-HT and NO level in vivo","volume-title":"Phytomedicine","author":"Chen","year":"2013"},{"key":"2024103012041994100_CIT0057","first-page":"116701","article-title":"Exploring the potential targets of Biling Weitong Granules on visceral hypersensitivity through integration of network pharmacology and in vivo analysis","volume-title":"J Ethnopharmacol","author":"Yang","year":"2023"},{"key":"2024103012041994100_CIT0058","first-page":"940463","article-title":"Ameliorative effect and mechanism of Si-Ni-San on chronic stress-induced diarrhea-irritable bowel syndrome in rats","volume-title":"Front Pharmacol","author":"Chen","year":"2022"},{"key":"2024103012041994100_CIT0059","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.carbpol.2017.12.058","article-title":"A review of polysaccharides from Schisandra chinensis and Schisandra sphenanthera: properties, functions and applications","volume":"184","author":"Li","year":"2018","journal-title":"Carbohydr Polym"},{"key":"2024103012041994100_CIT0060","first-page":"402","article-title":"Schisandra chinensis reverses visceral hypersensitivity in a neonatal\u2013maternal separated rat model","volume-title":"Phytomedicine","author":"Yang","year":"2012"},{"key":"2024103012041994100_CIT0061","first-page":"356","article-title":"The antibacterial activity of Berberis heteropoda Schrenk and its effect on irritable bowel syndrome in rats","volume-title":"Chin J Nat Med","author":"Li","year":"2020"},{"key":"2024103012041994100_CIT0062","first-page":"143","article-title":"The traditional uses, phytochemistry, and pharmacology of Atractylodes macrocephala Koidz.: a review","volume-title":"J Ethnopharmacol","author":"Zhu","year":"2018"},{"key":"2024103012041994100_CIT0063","first-page":"1010484","article-title":"Aqueous cinnamon extract ameliorates bowel dysfunction and enteric 5-HT synthesis in IBS rats","volume-title":"Front Pharmacol","author":"Yu","year":"2022"},{"key":"2024103012041994100_CIT0064","first-page":"43","article-title":"Activation of Nrf2\/HO-1 signaling: an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress","volume-title":"J Adv Res","author":"Zhang","year":"2021"},{"key":"2024103012041994100_CIT0065","first-page":"112442","article-title":"Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms","volume-title":"Biomed Pharmacother","author":"Slika","year":"2022"},{"key":"2024103012041994100_CIT0066","first-page":"5067","article-title":"Prenylated flavonoids in foods and their applications on cancer prevention","volume-title":"Crit Rev Food Sci Nutr","author":"Wen","year":"2022"},{"key":"2024103012041994100_CIT0067","first-page":"663","article-title":"Quercetin attenuates visceral hypersensitivity and 5-hydroxytryptamine availability in postinflammatory irritable bowel syndrome rats role of enterochromaffin cells in the colon","volume-title":"J Med Food","author":"Qin","year":"2019"},{"key":"2024103012041994100_CIT0068","first-page":"154419","article-title":"Potential of natural products in the treatment of irritable bowel syndrome","volume-title":"Phytomedicine","author":"Lu","year":"2022"},{"key":"2024103012041994100_CIT0069","first-page":"146","article-title":"Dietary flavonoids from modified apple reduce inflammation markers and modulate gut microbiota in mice","volume-title":"J Nutr","author":"Espley","year":"2014"},{"key":"2024103012041994100_CIT0070","first-page":"63","article-title":"Resveratrol for cancer therapy: challenges and future perspectives","volume-title":"Cancer Lett","author":"Ren","year":"2021"},{"key":"2024103012041994100_CIT0071","first-page":"109767","article-title":"A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications","volume-title":"Biomed Pharmacother","author":"Huang","year":"2020"},{"key":"2024103012041994100_CIT0072","first-page":"30","article-title":"Resveratrol improves brain-gut axis by regulation of 5-HT-dependent signaling in the rat model of irritable bowel syndrome","volume-title":"Front Cell Neurosci","author":"Yu","year":"2019"},{"key":"2024103012041994100_CIT0073","first-page":"13900","article-title":"Oral phyto-thymol ameliorates the stress induced IBS symptoms","volume-title":"Sci Rep","author":"Subramaniyam","year":"2020"},{"key":"2024103012041994100_CIT0074","first-page":"586","article-title":"Oridonin alleviates visceral hyperalgesia in a rat model of postinflammatory irritable bowel syndrome: role of colonic enterochromaffin cell and serotonin availability","volume-title":"J Med Food","author":"Zang","year":"2016"},{"key":"2024103012041994100_CIT0075","first-page":"810","article-title":"Natural compounds boldine and menthol are antagonists of human 5-HT3 receptors: implications for treating gastrointestinal disorders","volume-title":"Neurogastroenterol Motil","author":"Walstab","year":"2014"},{"key":"2024103012041994100_CIT0076","first-page":"154209","article-title":"Schisandrin C improves leaky gut conditions in intestinal cell monolayer, organoid, and nematode models by increasing tight junction protein expression","volume-title":"Phytomedicine","author":"Kim","year":"2022"},{"key":"2024103012041994100_CIT0077","first-page":"779","article-title":"Schisandrin C targets Keap1 and attenuates oxidative stress by activating Nrf2 pathway in Ang II-challenged vascular endothelium","volume-title":"Phytother Res","author":"Han","year":"2019"},{"key":"2024103012041994100_CIT0078","first-page":"415","article-title":"Schizandrin C exerts anti-neuroinflammatory effects by upregulating phase II detoxifying\/antioxidant enzymes in microglia","volume-title":"Int Immunopharmacol","author":"Park","year":"2013"},{"key":"2024103012041994100_CIT0079","first-page":"174220","article-title":"Identification and molecular study on the interaction of Schisandrin C with human 5-HT(3A) receptor","volume-title":"Eur J Pharmacol","author":"Eom","year":"2021"},{"key":"2024103012041994100_CIT0080","first-page":"706","article-title":"Effects of red ginseng on gut, microbiota, and brain in a mouse model of post-infectious irritable bowel syndrome","volume-title":"J Ginseng Res","author":"Yu","year":"2021"},{"key":"2024103012041994100_CIT0081","first-page":"109381","article-title":"A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits","volume-title":"Neuropharmacology","author":"Sarnoff","year":"2023"},{"key":"2024103012041994100_CIT0082","first-page":"775","article-title":"Gut microbiota-produced tryptamine activates an epithelial G-protein-coupled receptor to increase colonic secretion","volume-title":"Cell Host Microbe","author":"Bhattarai","year":"2018"},{"key":"2024103012041994100_CIT0083","first-page":"1724","article-title":"Tongxie formula reduces symptoms of irritable bowel syndrome","volume-title":"Clin Gastroenterol Hepatol","author":"Fan","year":"2017"},{"key":"2024103012041994100_CIT0084","first-page":"1614","article-title":"Chinese medicine diagnosis and treatment expert consensus opinion on IBS (2017)","volume":"58","author":"Zhang","year":"2017","journal-title":"J Tradit Chin Med"},{"key":"2024103012041994100_CIT0085","first-page":"8867","article-title":"Recent advances in pharmacological treatment of irritable bowel syndrome","volume":"20","author":"Georgia Lazaraki","year":"2014","journal-title":"World J Gastroenterol"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/76\/2\/75\/60221415\/rgad120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/76\/2\/75\/60221415\/rgad120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T16:25:01Z","timestamp":1730305501000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/76\/2\/75\/7515149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":85,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,1]]},"published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgad120","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2,1]]},"published":{"date-parts":[[2024,2,1]]}}}